In Section C, individuals will acquire ABBV-744 and oral navitoclax. In Phase D, members will get ABBV-744 and ruxolitinib. Individuals will obtain treatment right up until sickness progression or even the individuals are unable to tolerate the study drugs. - Participant eaten grapefruit or grapefruit goods within three times prior https://anatoled703bzw2.wikififfi.com/user